Compare Humana Inc (HUM) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs QUALCOMM, Inc. — how do they compare? Humana Inc trades at $400 (market cap $47.81B), while QUALCOMM, Inc. trades at $173.75 (market cap $179.52B). The key difference: QUALCOMM, Inc. is far larger — about 3.8× Humana Inc's market cap, and QUALCOMM, Inc. pays the higher dividend (2.16%). Which is the better fit depends on your goals.
| HUM | QCOM | |
|---|---|---|
Market Cap | $47.81B | $179.52B |
Sector | Health | Technology |
52-Week High | $409.42 | $251.10 |
52-Week Low | $163.67 | $124.07 |
Enterprise Value | $56.85B | $184.99B |
Dividend Yield | 0.89% | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Qualcomm (QCOM) trades at $170.32, down 0.85% on the day, with a bearish technical signal despite recent earnings beats. The company reported strong profitability with a 54.8% gross margin and 22.31% net margin, though net income declined to $5.54B in 2025. Recent news highlights competitive pressures from Nvidia's entry into PC chips but also Qualcomm's AI diversification efforts in automotive and data centers.
The outlook is mixed: analyst consensus targets $228.22 (34% upside) with 43% buy ratings, but near-term risks include smartphone demand softness and margin pressures. Long-term growth depends on successful expansion into AI and automotive markets, balancing current valuation at 18.5x P/E against execution challenges in a competitive semiconductor landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
